Brief: Sino Biopharmaceutical Announces Interim Dividend Of HK3 Cents Per Share
13/08/2024 09:37
Aug 13 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* HY PROFIT ATTRIBUTABLE RMB3.02 BILLION VERSUS RMB1.26
BILLION
* HY REVENUE RMB 15.87 BILLION
* PAYMENT OF AN INTERIM DIVIDEND OF HK3 CENTS PER SHARE
* LOOKING TO VAST GLOBAL MARKET TO ACCELERATE ITS INNOVATION
AND
DEVELOPMENT THROUGH GLOBALIZATION
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit